Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Vaccine	2,704
Overall Study	STARTED	Placebo	2,700
Overall Study	Modified Intent-to-Treat (MITT) Cohort	Vaccine	2,695
Overall Study	Modified Intent-to-Treat (MITT) Cohort	Placebo	2,689
Overall Study	MITT Infected Cohort	Vaccine	151
Overall Study	MITT Infected Cohort	Placebo	143
Overall Study	Week 26 At-Risk Cohort	Vaccine	2,430
Overall Study	Week 26 At-Risk Cohort	Placebo	2,393
Overall Study	Immunogenicity Cohort	Vaccine	120
Overall Study	Immunogenicity Cohort	Placebo	10
Overall Study	COMPLETED	Vaccine	2,557
Overall Study	COMPLETED	Placebo	2,557
Overall Study	NOT COMPLETED	Vaccine	147
Overall Study	NOT COMPLETED	Placebo	143

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02968849/flow